Purpose: Medication errors reported to FDA as adverse events in which methotrexate was identified as a possible contributor were studied. Methods: All adverse-event reports submitted to FDA ...

Low-dose methotrexate was not clinically effective for lowering blood pressure among patients without rheumatic disease who have cardiovascular risk factors.